BioCryst Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 86   

Articles published

BCRX 11.72 -0.34 (-2.82%)
price chart
Reaction to Confirmed Ebola Case in U.S. � UPDATED
BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) was up 5% at $9.78 in the after-hours, but that was after a 6.7% drop to $9.78 in regular trading.
Biocryst Pharmaceuticals Inc. (BCRX) Is Rising After U.S. Ebola Case Confirmed  RTT News
As Ebola spreads, drug stocks surge  CNNMoney
Related articles »  
Perilous Reversal Stock: Biocryst Pharmaceuticals (BCRX)
BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases.
BioCryst And NewLink Surge On Latest US Ebola Case
BioCryst Pharmaceuticals, Inc. (BCRX) surged 14.7% yesterday following news that a nurse, who had been in direct physical contact with Thomas Duncan, had also contracted Ebola.
Small Cap Biotech Game Changers: NewLink Genetics Corp (NASDAQ:NLNK ...  StreetWise Report
Biotech Gainers: Arrowhead Research Corp. (NASDAQ:ARWR), BioCryst ...  WallStreet Scope
Related articles »  
Heavy Early Morning Activity On Biocryst Pharmaceuticals (BCRX)
BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases.
Why Investors Are Tracking: BioCryst Pharmaceuticals (NASDAQ:BCRX ...  WallStreet Scope
Related articles »  
BioCryst Pharmaceuticals Inc. (BCRX) Has Broken Out Of Today's Range
(RTTNews.com) - BioCryst Pharmaceuticals Inc. ( BCRX ) has been trading in a range since the open Tuesday, but has broken out higher in the last few minutes on increased volume.
Related articles »  
BioCryst Pharmaceutical: Short-Term Pump-And-Dump On Ebola Fear, A Long ...
One company that I believe to have a solid pipeline, but is currently significantly overvalued is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). Based on the current chart analysis of the stock, it's been enjoying a recent run up since the fear of Ebola ...
Strong On High Relative Volume: Biocryst Pharmaceuticals (BCRX)
BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases.
Related articles »  
Weakness Seen in BioCryst Pharmaceuticals (BCRX): Stock Tumbles 8.0 ...
BioCryst Pharmaceuticals, Inc. ( BCRX ) saw a big move last session, as the company's shares fell by nearly 8% on the day.
Related articles »  
Morning Buzz: RadioShack Corp. (RSH), Tekmira Pharmaceuticals (TKMR ...
BioCryst Pharmaceuticals, Inc., currently valued at $816.94M, has a median Wall Street price target of $18.00 with a high target of $24.00.
Related articles »  
BioCryst Pharmaceuticals (BCRX) Jumps: Stock Up 14.7% - Tale of the Tape
BioCryst Pharmaceuticals, Inc. ( BCRX ) was a big mover last session with its shares rising nearly 15% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.
Related articles »